Lipoprotein(a) as a Risk Factor for Myocardial Infarction, Cardiovascular, and All-Cause Mortality in Patients with Type 2 Diabetes Mellitus
Jerneja Čuješ, Vojko Kanič, Petra Povalej Bržan, David Šuran · 2026
Read Lipoprotein(a) as a Risk Factor for Myocardial Infarction, Cardiovascular, and All-Cause Mortality in Patients with Type 2 Diabetes Mellitus by Jerneja Čuješ, Vojko Kanič, Petra Povalej Bržan, David Šuran (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13205150.txt.
Description
Jerneja Čuješ, Vojko Kanič, Petra Povalej Bržan, and David Šuran examine whether a blood fat called lipoprotein(a) predicts heart attacks and death in people with type 2 diabetes. Their paper appeared in 2026.
The team followed 2,967 patients who were treated in hospital between 2000 and 2018 and had no earlier heart attack. Over the follow-up, about one in eight patients had a heart attack. High levels of the blood fat meant a clearly higher risk of a first heart attack in women, but no clear link showed in men. Higher levels also tracked with more deaths from heart and vessel disease in the group as a whole. The authors say a simple blood test could help flag women with diabetes who face extra risk.
Catalog record
| CREATOR | Jerneja Čuješ, Vojko Kanič, Petra Povalej Bržan, David Šuran |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 26 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |